References
- Snider WD, Simpaon DM, Nielsen S, et al. Neurological complications of acquired immune deficiency syndrome: analysts of 50 patients. Ann Neurol1983: 14(4): 403–18
- Rosenblum ML, Levy RM, Bredesen DE, eds. AIDS and the nervous system. New York: Raven Press, 1988: 203–19
- Navia BA, Price RW. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol 1987: 44(1): 65–9
- Navia BA, Cho ES, Petito CK, et al. The AIDS dementia complex. II. Neuropathology. Ann Neurol 1986: 19(6): 525–35
- Navia BA, Jordan BD, Price RW. The AIDS dementia complex. 1. Clinical features. Ann Neurol 1986: 19(6): 517–24
- Price RW, Brew B, Sidtis J, et al. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988: 239(4840): 586–92
- Goethe KE, Mitchell JE, Marshall DW, et al. Neuropsychological and neurological function of human immunodeficiency virus seropositive asymptomatic individuals. Arch Neurol 1989: 46(2): 129–133
- McArthur JC, Cohen BA, Farzedegan H, et al. Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings. Ann Neurol 1988: 23(Suppl): S34–7
- Petito CK, Navia BA, Cho ES, et al. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 1985: 312(14): 874–9
- Chaisson RE, Allain JP, Leuther M, et al. Significant changes in HIV antigen level in the serum of patients treated with azidothymidine. (Letter) N Engl J Med 1986: 315(25): 1610–1
- Fischl MA, Richman DD, Grieco MH, et al. The efficiency of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a doubleblind, placebo-controlled trial. N Engl J Med 1987: 317(4): 185–191
- Yarchoan R, Thomas RV. Grafman J, et al. Long-term administration of 3′-azido-2′,3′-dideoxythymidine to patients with AIDS-related neurological disease. Ann Neurol 1988: 23(Suppl): S82–7